SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000935836-21-000086
Filing Date
2021-02-11
Accepted
2021-02-11 16:54:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 akero13g.htm SC 13G 40706
  Complete submission text file 0000935836-21-000086.txt   42225
Mailing Address 350 MADISON AVENUE 20TH FLOOR NEW YORK NY 10017
Business Address 350 MADISON AVENUE 20TH FLOOR NEW YORK NY 10017 2127166576
ALKEON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001230239 (see all company filings)

IRS No.: 134200093 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Subject) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91047 | Film No.: 21620534
SIC: 2834 Pharmaceutical Preparations